ESCLEROTERAPIA E CLAREAMENTO DENTAL EM PACIENTE COM HEMANGIOMA ORAL: UM ESTUDO DE CASO
Resumo
O hemangioma é considerado um tumor vascular benigno comum na infância, com mais de 60% dos casos que afetam a cabeça e pescoço, sendo o lábio mais afetado na região oral e são mais comuns nas mulheres. Quando afetada, a principal queixa relatada pelos pacientes é a estética. Entre as alternativas de tratamento, a escleroterapia tem sido utilizada com sucesso nessas regiões e pode estar associada ao clareamento dental em consultório para pacientes que buscam tratamentos estéticos. O objetivo deste artigo é relatar um caso clínico de hemangioma do lábio superior usando escleroterapia com 0,05 g/ml de oleato de monoetanolamina (Ethamolin®) como um tratamento associado ao procedimento estético de clareamento dental (Whiteness HP Automixx, FGM), em uma paciente do sexo feminino, considerando as características clínicas e os métodos de diagnóstico desta lesão. O clareamento dental no consultório com peróxido de hidrogênio 35% pode ser indicado para pacientes com hemangioma oral, por ser um procedimento seguro e eficaz.
Texto completo:
PDFReferências
ALEXANDER, M. D. et al. Percutaneous sclerotherapy with ethanolamine oleate for lymphatic malformations of the head and neck. Journal of Neurointerventional Surgery. v. 6, n. 9, p. 691-94, 2014. GROVER, S. et al. Hydrocortisone associated hypomania in a child responding to shifting back to prednisolone. Journal of Cutaneous and Aesthetic Surgery. v. 5, n. 3, p. 201-03, 2012.
ALMEIDA, A. F. et al. Genotoxic potential of 10% and 16% carbamide peroxide in dental bleaching. Brazilian Oral Research. p. 29, 2015.
ARMÊNIO, R. V. et al. The Effect of Fluoride Gel Use on Bleaching Sensitivity. The Journal of the American Dental Association. v. 139, n. 5, p. 592-97, 2008.
BASTING, R. T. et al. Clinical comparative study of the effectiveness of and tooth sensitivity to 10% and 20% carbamide peroxide home-use and 35% and . 38% hydrogen peroxide in-office bleaching materials containing desensitizing agents. Operative Dentistry. v. 37, n. 5, p. 464-73, 2012.
BATISTA, A. C. et al. Sclerotherapy of benign oral vascular lesion with ethanolamine oleate: An open clinical trial with 30 lesions. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology. v. 100, n. 5, p. 579-84, 2005.
BERNARDON, J. K. et al. Clinical performance of vital bleaching techniques. Operative Dentistry. v. 35, n. 1, p. 3-10, 2010.
BERNARDON, J. K. et al. Comparison of treatment time versus patient satisfaction in at-home and in-office tooth bleaching therapy. Journal of Prosthetic Dentistry. v. 114, n. 6, p. 826-30, 2015.
BOON, L. M. Congenital hemangioma: evidence of accelerated involution. The Journal of pediatrics. v. 128, n. 3, p. 329-35, 1996.
CANEPPELE, T. M. F. et al. Influência da embebição dental em substâncias com corantes na eficácia do clareamento dental com peróxido de carbamida a 16%. Arquivos em Odontologia. v. 14, p. 45, 2016.
CAREY, C. M. Tooth whitening: what we now know. Journal of Evidence-Based Dental Practice. v. 14, p. 70-76, 2004.
CHANG, L. C. Growth characteristics of infantile hemangiomas: implications for management Pediatrics. v. 122, n. 2, p. 360-7, 2008.
COSTA, V. A. Haimowitz R, Cheng YI, et al. Social Impact of Facial Infantile Hemangiomas in Preteen Children. JAMA Otolaryngology Head Neck Surgery. v. 142, n. 1, p. 13-9, 2016.
CRUZ, F. L. G, et al. Diagnóstico diferencial de hemangioma por meio da vitropressão. Revista Gaúcha de Odontologia. v. 59, n. 1, p.125-29, 2011.
da ROCHA, A. B. M. et al. Escleroterapia de hemangioma em borda lateral de língua: relato de caso. Revista de Ciências Médicas e Biológicas. v. 13, n. 3, p. 398-402, 2015.
da SILVA, W. B. et al. Oral capillary hemangioma: a clinical protocol of diagnosis and treatment in adults. Journal of Oral and Maxillofacial Surgery. v. 18, n. 4, p. 431-7, 2014.
DAWSON, P. F. et al. A clinical study comparing the efficacy and sensitivity of home vs combined whitening. Operative Dentistry. v. 36, n. 5, p. 460-66, 2011.
de ALMEIDA, L. C. et al. At-Home Bleaching: Color Alteration, Hydrogen Peroxide Diffusion and Cytotoxicity. Brazilian Dental Journal. v. 26, n. 4, p. 378-83, 2015.
de GEUS, J. L. et al. Evaluation of genotoxicity and efficacy of at-home bleaching in smokers: a single-blind controlled clinical trial. Operative Dentistry. v. 40, n. 5, p. 47-55, 2015.
de LA PEÑA, A. V., LOPEZ, R. M. Randomized clinical trial on the efficacy and safety of four professional at-home tooth whitening gels. Operative Dentistry. v. 39, n. 2, p. 136-43, 2014.
de LA PEÑA, V. A., CABRITA, O. B. Comparison of the clinical efficacy and safety of carbamide peroxide and hydrogen peroxide in at-home bleaching gels. Quintessence International. v. 7, p. 7, 2006.
GIACHETTI, L. et al. A Randomized Clinical Trial Comparing At-Home and In-Office Tooth Whitening Techniques: A nine-month follow-up. The Journal of the American Dental Association. v. 141, n. 11, p. 1357-64, 2010.
GURGAN, S. et al. Different light-activated in-office bleaching systems: a clinical evaluation. Lasers in Medical Sciense. v. 25, n. 6, p. 817-22, 2010.
HAYWOOD, V. B., HEYMANN, H. O. Nightguard vital bleaching. Quintessence International. v. 20, n. 3, p. 173-76, 1989.
HIROSHIMA, Y. et al. Regulation of antimicrobial peptide expression in human gingival keratinocytes by interleukin-1?. Archives of oral biology. v. 56, n. 8, p. 761-7, 2011.
HYNES, S. et al. Complicated infantile hemangioma of the lip: outcomes of early versus late resection. Plastic and Reconstructive Surgery. v. 131, n. 1, p. 373-9, 2013.
JIMÉNEZ, P. C. et al. La Escleroterapia como una alternativa en el Tratamiento de los Hemangiomas de los Tejidos Blandos de la Cavidad Bucal. Acta Odontológica Venezolana. v. 38, p. 4-8, 2000.
KOSE, C. et al. Comparison of the Effects of In-office Bleaching Times on Whitening and Tooth Sensitivity: A Single Blind, Randomized Clinical Trial. Operative Dentistry. v. 41, n. 2, p. 138-45, 2016.
MANDÚ, A. L. C. et al. Escleroterapia de hemangioma: relato de caso. Revista de Cirurgia e Traumatologia Buco-maxilo-facial. v. 13, n. 1, p. 71-6, 2013.
MEIRELES, S. S. et al. Efficacy and safety of 10% and 16% carbamide peroxide tooth-whitening gels: a randomized clinical trial. Operative Dentistry. v. 33, n. 6, p. 606-12, 2008.
NISHIKAWA, M. et al. Venous malformation of the tongue in a child treated by sclerotherapy with ethanolamine oleate: a case report. Journal of Pediatric Surgery. v. 41, n. 3, p. 599-600, 2006.
O, T.M-J, et al. Distribution, Clinical Characteristics, and Surgical Treatment of Lip Infantile Hemangiomas. JAMA Facial Plastic Surgery. v. 15, n. 4, p. 292, 2013.
QUEIROZ, S. I. M. L. et al. Treatment of oral hemangioma with sclerotherapy: case report. Jornal Vascular Brasileiro. v. 13, n.3, p. 249-53, 2014.
REIS, A. et al. Clinical effects of prolonged application time of an in-office bleaching gel. Operative Dentistry. v. 36, n. 6, p. 590-96, 2011.
REIS, A. et al. Efficacy of and effect on tooth sensitivity of in-office bleaching gel concentrations: a randomized clinical trial. Operative Dentistry. v. 38, n. 4, p. 386-93, 2013.
REZENDE, M. et al. Clinical effects of exposure to coffee during at-home vital bleaching. Operative Dentistry. v. 38, n. 6, p. 229-36, 2013.
REZENDE, M. et al. Clinical Evaluation of Genotoxicity of In-office Bleaching. Operative Dentistry. v. 41, n. 6, p. 578-86, 2016.
REZENDE, M. et al. Pre- and postoperative dexamethasone does not reduce bleaching-induced tooth sensitivity: A randomized, triple-masked clinical trial. The Journal of the American Dental Association. v. 147, n. 1, p. 41-49, 2016.
RIBAS, M. O. et al. Hemangioma bucal: escleroterapia com oleato de etanolamina. Revisão da literatura e apresentação de caso. Revista de Clínica e Pesquisa Odontológica. v. 1, n. 2, p. 31-6, 2004.
ROCHA, L. B. et al. Hemangioma da cavidade bucal. Revista Gaúcha de Odontologia. v. 3, p. 48, 2000.
SAMORODNITZKY-NAVEH, G. R. et al. Patients' satisfaction with dental esthetics. The Journal of the American Dental Association. v. 138, n. 6, p. 805-8, 2007.
SELIM, H. et al. Use of sclerosing agent in the management of oral and perioral hemangiomas: review and case reports. Medical Science Monitor. v. 13, n. 9, p. 114-9, 2007.
SEO, J. et al. Escleroterapia de hemangioma labial. Odonto. v. 17, n. 34, p. 106-12, 2009.
SWIFT, A., SIEGLER, J. Intraturbinate ethanolamine oleate as a method of treatment in chronic non specific rhinitis. The Journal of Laryngology & Otology. v. 100, n. 4, p. 417-20, 1986.
TIPTON, D. A. et al. Effects of a bleaching agent on human gingival fibroblasts. Journal of periodontology. v. 66, n. 1, p. 7-13, 1995.
TOLLEFSON, M.M., FRIEDEN, I. J. Early growth of infantile hemangiomas: what parents' photographs tell us Pediatrics. v. 130, n. 2, p. 314-20, 2012.
WANG, L. et al. Tratamento de hemangioma bucal com agente esclerosante. Revista Odontológica do Brasil-Central. v. 7, n. 24, p. 20-22, 1998.
YANES, D. A. et al. Infantile Hemangiomas of the Lip: Patterns, Outcomes, and Implications. Pediatric Dermatology. v. 33, n. 5, p. 511-7, 2016.
ZHAO, K. et al. Clinical comparison between two bleaching techniques: a 180-day follow-up stu, p. dy. Quintessence International. v 44, n. 8, p. 601-7, 2013.
Apontamentos
- Não há apontamentos.
Direitos autorais 2020 Revista Journal of Health - ISSN 2178-3594